Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Skyworks Solutions Inc (SWKS) vs Zoetis Inc (ZTS) Price & Performance

Skyworks Solutions IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Skyworks Solutions Inc vs Zoetis Inc — how do they compare? Skyworks Solutions Inc trades at $76.65 (market cap $12.15B), while Zoetis Inc trades at $74.76 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2.5× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays the higher dividend (4.13%). Which is the better fit depends on your goals — on Pluang, investors hold Skyworks Solutions Inc for 50 Days and Zoetis Inc for 70 Days on average.

SWKSZTS
Market Cap
$12.15B$30.20B
Volume
7,390,8106,175,327
Sector
TechnologyHealth
52-Week High
$91.45$147.53
52-Week Low
$52.50$69.09
Typical Hold Time
50 Days70 Days
Enterprise Value
$12.03B$37.76B
Dividend Yield
4.13%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Skyworks Solutions Inc

Skyworks Solutions (SWKS) trades at $76.35, down 8.49% in the last session, reflecting near-term pressure despite beating earnings estimates in recent quarters. The stock exhibits a bearish technical signal, with key support at $76, while fundamentals show declining revenue and net income margins over recent years. The pending merger with Qorvo represents a significant strategic development, aimed at enhancing scale and market diversification.

The investment outlook is mixed, with analyst consensus leaning bullish (60% buy ratings) and a price target of $78.80 offering modest upside. However, risks include execution challenges from the merger, competitive pressures in semiconductors, and ongoing profitability declines. The stock's current valuation at a P/E of 41.84 appears elevated relative to earnings growth trends.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SWKS
19% Buy81% Sell
Avg holding period · 50 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Skyworks Solutions Inc

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Read more on SWKS →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →